NDRA vs. JAGX
NDRA (ENDRA Life Sciences Inc.) and JAGX (Jaguar Health, Inc.) are both stocks. Both are in the Healthcare sector — NDRA in Diagnostics & Research, JAGX in Biotechnology. Over the past 5 years, NDRA returned -85.62%/yr vs -95.54%/yr for JAGX. At a 0.13 correlation, their price movements are largely independent.
Performance
NDRA vs. JAGX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NDRA achieves a 5.30% return, which is significantly higher than JAGX's -88.68% return.
NDRA
- 1D
- 0.85%
- 1M
- -1.65%
- YTD
- 5.30%
- 6M
- -13.27%
- 1Y
- 33.99%
- 3Y*
- -87.88%
- 5Y*
- -85.62%
- 10Y*
- —
JAGX
- 1D
- 4.45%
- 1M
- 1.33%
- YTD
- -88.68%
- 6M
- -90.41%
- 1Y
- -97.36%
- 3Y*
- -95.09%
- 5Y*
- -95.54%
- 10Y*
- -89.14%
NDRA vs. JAGX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NDRA ENDRA Life Sciences Inc. | 5.30% | -27.64% | -99.83% | -47.91% | -70.58% | -7.76% | -55.36% | 12.00% | -69.14% | 24.62% |
JAGX Jaguar Health, Inc. | -88.68% | -96.31% | -88.88% | -97.68% | -91.64% | -57.46% | 1.75% | -95.00% | -89.10% | -73.56% |
Correlation
The correlation between NDRA and JAGX is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.05 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Jul 3, 2017 | 0.13 |
Fundamentals
NDRA:
$3.75M
JAGX:
$7.11M
NDRA:
-$9.31
JAGX:
-$33.07
NDRA:
$0.00
JAGX:
$11.51M
NDRA:
-$117.76K
JAGX:
$7.74M
NDRA:
-$3.74M
JAGX:
-$45.91M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NDRA vs. JAGX — Risk / Return Rank
NDRA
JAGX
NDRA vs. JAGX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ENDRA Life Sciences Inc. (NDRA) and Jaguar Health, Inc. (JAGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| NDRA | JAGX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.83 | ||
| Sortino ratioReturn per unit of downside risk | +4.21 | ||
| Omega ratioGain probability vs. loss probability | 1.23 | 0.71 | +0.52 |
| Calmar ratioReturn relative to maximum drawdown | 0.54 | -1.00 | +1.54 |
| Martin ratioReturn relative to average drawdown | 0.80 | -1.41 | +2.20 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| NDRA | JAGX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.20 | -0.63 | +0.83 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.60 | -0.69 | +0.10 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | -0.51 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.53 | -0.52 | -0.01 |
Drawdowns
NDRA vs. JAGX - Drawdown Comparison
The maximum NDRA drawdown since its inception was -100.00%, roughly equal to the maximum JAGX drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for NDRA and JAGX.
Loading charts...
Drawdown Indicators
| NDRA | JAGX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -100.00% | 0.00% |
Max Drawdown (1Y)Largest decline over 1 year | -63.12% | -97.60% | +34.48% |
Max Drawdown (3Y)Largest decline over 3 years | -99.93% | -99.99% | +0.06% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | -100.00% | 0.00% |
Max Drawdown (10Y)Largest decline over 10 years | — | -100.00% | — |
Current DrawdownCurrent decline from peak | -100.00% | -100.00% | 0.00% |
Average DrawdownAverage peak-to-trough decline | -79.18% | -94.08% | +14.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 42.64% | 69.16% | -26.52% |
Volatility
NDRA vs. JAGX - Volatility Comparison
The current volatility for ENDRA Life Sciences Inc. (NDRA) is 26.12%, while Jaguar Health, Inc. (JAGX) has a volatility of 37.07%. This indicates that NDRA experiences smaller price fluctuations and is considered to be less risky than JAGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NDRA | JAGX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 26.12% | 37.07% | -10.95% |
Volatility (6M)Calculated over the trailing 6-month period | 63.02% | 141.94% | -78.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 170.95% | 153.94% | +17.01% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 143.61% | 137.94% | +5.67% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 129.17% | 173.41% | -44.24% |
Dividends
NDRA vs. JAGX - Dividend Comparison
Neither NDRA nor JAGX has paid dividends to shareholders.
Financials
NDRA vs. JAGX - Financials Comparison
This section allows you to compare key financial metrics between ENDRA Life Sciences Inc. and Jaguar Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NDRA and JAGX have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
JAGX has higher volatility (37.07%) compared to NDRA (26.12%). In terms of maximum drawdown, NDRA dropped -100.00% vs JAGX's -100.00%.
NDRA currently has the higher Sharpe Ratio (0.20 vs -0.63), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NDRA and JAGX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer